Hemostasis Closes Acquisition of Fiagon Medical Technologies
St. Paul, Minn. & BERLIN--(BUSINESS WIRE)—Hemostasis LLC, a techological leader in ear, nose and throat (“ENT”) healing, today announced it closed the previously announced transaction to acquire Fiagon Medical Technologies, a leader in electromagnetic surgical navigation solutions. Terms of the deal were not disclosed.
